168 related articles for article (PubMed ID: 35634444)
41. Using mRNAsi to identify prognostic-related genes in endometrial carcinoma based on WGCNA.
Liu J; Wu Z; Sun R; Nie S; Meng H; Zhong Y; Nie X; Cheng W
Life Sci; 2020 Oct; 258():118231. PubMed ID: 32791150
[TBL] [Abstract][Full Text] [Related]
42. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821
[TBL] [Abstract][Full Text] [Related]
43. An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.
Chen D; Wang M; Guo Y; Wu W; Ji X; Dou X; Tang H; Zong Z; Zhang X; Xiong D
Cancer Med; 2021 Sep; 10(17):5936-5947. PubMed ID: 34313009
[TBL] [Abstract][Full Text] [Related]
44. Development of Potential Prognostic Biomarkers Based on DNA Methylation-Driven Genes for Patients with Endometrial Cancer.
Lu Y; Tang W; Wang X; Kang X; You J; Chen L
Int J Gen Med; 2021; 14():10541-10555. PubMed ID: 35002309
[TBL] [Abstract][Full Text] [Related]
45. Construction of an Immune-Autophagy Prognostic Model Based on ssGSEA Immune Scoring Algorithm Analysis and Prognostic Value Exploration of the Immune-Autophagy Gene in Endometrial Carcinoma (EC) Based on Bioinformatics.
Xu X; Lu F; Fang C; Liu S
J Healthc Eng; 2022; 2022():7832618. PubMed ID: 35242299
[TBL] [Abstract][Full Text] [Related]
46. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
[TBL] [Abstract][Full Text] [Related]
47. Integrated bioinformatics data analysis reveals a risk signature and PKD1 induced progression in endometrial cancer patients with postmenopausal status.
Cheng Y; Zhang S; Qiang Y; Dong L; Li Y
Aging (Albany NY); 2022 Jul; 14(13):5554-5570. PubMed ID: 35816294
[TBL] [Abstract][Full Text] [Related]
48. Identification of Key Prognostic-Related miRNA-mRNA Pairs in the Progression of Endometrial Carcinoma.
Dong Y; Zhang T; Li X; Yu F; Yu H; Shao S
Gynecol Obstet Invest; 2022; 87(1):12-21. PubMed ID: 35081534
[TBL] [Abstract][Full Text] [Related]
49. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
50. Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer.
Lu J; Liang J; Xu M; Wu Z; Cheng W; Wu J
Bioengineered; 2021 Dec; 12(1):4201-4216. PubMed ID: 34338136
[TBL] [Abstract][Full Text] [Related]
51. Prognostic factors and genes associated with endometrial cancer based on gene expression profiling by bioinformatics analysis.
Zhang Y; Zhang W; Li X; Li D; Zhang X; Yin Y; Deng X; Sheng X
Arch Gynecol Obstet; 2016 Jun; 293(6):1287-95. PubMed ID: 26437953
[TBL] [Abstract][Full Text] [Related]
52. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z
Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822
[TBL] [Abstract][Full Text] [Related]
53. Analysis of Genetic Alterations Related to DNA Methylation in Testicular Germ Cell Tumors Based on Data Mining.
Yu X; Han Y; Liu S; Jiang W; Song Y; Tong J; Qiao T; Lv Z; Li D
Cytogenet Genome Res; 2021; 161(6-7):382-394. PubMed ID: 34433169
[TBL] [Abstract][Full Text] [Related]
54. Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma.
Ma H; Feng PH; Yu SN; Lu ZH; Yu Q; Chen J
BMC Cancer; 2022 May; 22(1):543. PubMed ID: 35562682
[TBL] [Abstract][Full Text] [Related]
55. Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer.
Ying J; Xu T; Wang Q; Ye J; Lyu J
Epigenetics; 2018; 13(5):490-504. PubMed ID: 29912667
[TBL] [Abstract][Full Text] [Related]
56. Prognostic and predictive value of a DNA methylation-driven transcriptional signature in hepatocellular carcinoma.
Luo HB; Cao PB; Zhou GQ
Yi Chuan; 2020 Aug; 42(8):775-787. PubMed ID: 32952113
[TBL] [Abstract][Full Text] [Related]
57. Identification of epigenetic methylation-driven signature and risk loci associated with survival for colon cancer.
Wang X; Zhang D; Zhang C; Sun Y
Ann Transl Med; 2020 Mar; 8(6):324. PubMed ID: 32355768
[TBL] [Abstract][Full Text] [Related]
58. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Zhu Q; Tian G; Gao J
Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
[TBL] [Abstract][Full Text] [Related]
59. Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer.
Gao Y; Wang X; Li S; Zhang Z; Li X; Lin F
Med Sci Monit; 2021 May; 27():e930025. PubMed ID: 34003815
[TBL] [Abstract][Full Text] [Related]
60. Genome-wide characterization of aberrant DNA methylation patterns and the potential clinical implications in patients with endometrial cancer.
Wang Y; Liu D; Jin X; Song H; Lou G
Pathol Res Pract; 2019 Jan; 215(1):137-143. PubMed ID: 30449607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
